Association of C-terminal ubiquitin hydrolase BRCAl-associated protein 1 with cell cycle regulator host cell factor 1

Molecular and Cellular Biology

Volumn 29, Issue 8, 2009, Pages 2181-2192

  Misaghi, Shahram ^a   Ottosen, Søren ^b   Izrael Tomasevic, Anita ^a   Arnott, David ^a   Lamkanfi, Mohamed ^a   Lee, James ^a   Liu, Jinfeng ^a   O'Rourke, Karen ^a   Dixit, Vishva M ^a   Wilson, Angus C ^b  

^a GENENTECH INC   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED PROTEIN 1; BRCA1 PROTEIN; HOST CELL FACTOR 1; LYSINE; NUCLEAR PROTEIN; PROTEIN VP16; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

ANIMALS; BINDING SITES; CELL CYCLE PROTEINS; CELL PROLIFERATION; HOST CELL FACTOR C1; INTERPHASE; MICE; PROTEIN BINDING; UBIQUITIN THIOLESTERASE; UBIQUITIN-PROTEIN LIGASES;

MUS MUSCULUS; SIMPLEXVIRUS;

EID: 64649106796     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01517-08     Document Type: Article

References (50)

1. Angeloni, D. 2007. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease. Brief Funct. Genomic Proteomic 6:19-39.
2. Arnott, D., A. Kishiyama, E. A. Luis, S. G. Ludlum, J. C. Marsters, Jr., and J. T. Stults. 2002. Selective detection of membrane proteins without antibodies: a mass spectrometric version of the Western blot. Mol. Cell. Proteomics 1:148-156.
3. Buchhagen, D. L., L. Qiu, and P. Etkind. 1994. Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3pl4.3-3p21.3 in sporadic breast-cancer development. Int. J. Cancer 57:473-479.
4. Coupier, I., P. Y. Cousin, D. Hughes, P. Legoix-Ne, A. Trehin, O. M. Sinilni-kova, and D. Stoppa-Lyonnet. 2005. BAP1 and breast cancer risk. Fam. Cancer 4:273-277.
5. Dang, L. C, F. D. Melandri, and R. L. Stein. 1998. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. Biochemistry 37:1868-1879.
6. Das, C., Q. Q. Hoang, C. A. Kreinbring, S. J. Luchansky, R. K. Meray, S. S. Ray, P. T. Lansbury, D. Ringe, and G. A. Petsko. 2006. Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hy-drolase UCH-L1. Proc. Natl. Acad. Sci. USA 103:4675-4680.
7. Dejosez, M., J. S. Krumenacker, L. J. Zitur, M. Passeri, L. F. Chu, Z. Songyang, J. A. Thomson, and T. P. Zwaka. 2008. Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell 133:1162-1174.
8. Dou, Y., T. A. Milne, A. J. Tackett, E. R. Smith, A. Fukuda, J. Wysocka, C. D. Allis, B. T. Chait, J. L. Hess, and R. G. Roeder. 2005. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 121:873-885.
9. Freiman, R. N., and W. Herr. 1997. Viral mimicry: common mode of association with HCF by VP16 and the cellular protein LZIP. Genes Dev. 11:3122-3127.
10. Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin-proteasome pro-teolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:373-428.
11. Goto, H., S. Motomura, A. C. Wilson, R. N. Freiman, Y. Nakabeppu, K. Fukushima, M. Fujishima, W. Herr, and T. Nishimoto. 1997. A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function. Genes Dev. 11:726-737.
12. Hamazaki, J., S. Iemura, T. Natsume, H. Yashiroda, K. Tanaka, and S. Murata. 2006. A novel proteasome interacting protein recruits the deubiq-uitinating enzyme UCH37 to 26S proteasomes. EMBO J. 25:4524-4536.
13. Jensen, D. E., M. Proctor, S. T. Marquis, H. P. Gardner, S. I. Ha, L. A. Chodosh, A. M. Ishov, N. Tommerup, H. Vissing, Y. Sekido, J. Minna, A. Borodovsky, D. C. Schultz, K. D. Wilkinson, G. G. Maul, N. Barlev, S. L. Berger, G. C. Prendergast, and F. J. Rauscher III. 1998. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16:1097-1112.
14. Jensen, D. E., and F. J. Rauscher III. 1999. Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1-binding protein BAP1. Cancer Lett. 143(Suppl. 1):S13-S17.
15. Johnston, S. C., C. N. Larsen, W. J. Cook, K. D. Wilkinson, and C. P. Hill. 1997. Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 Å resolution. EMBO J. 16:3787-3796.
16. Julien, E., and W. Herr. 2004. A switch in mitotic histone H4 lysine 20 methylation status is linked to M phase defects upon loss of HCF-1. Mol. Cell 14:713-725.
17. Julien, E., and W. Herr. 2003. Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF-1. EMBO J. 22:2360-2369.
18. Knez, J., D. Piluso, P. Bilan, and J. P. Capone. 2006. Host cell factor-1 and E2F4 interact via multiple determinants in each protein. Mol. Cell. Biochem. 288:79-90.
19. Koulich, E., X. Li, and G. N. Demartino. 2008. Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome. Mol. Biol. Cell 19:1072-1082.
20. Kristie, T. M, J. L. Pomerantz, T. C. Twomey, S. A. Parent, and P. A, Sharp. 1995. The cellular C1 factor of the herpes simplex virus enhancer complex is a family of polypeptides. J. Biol. Chem. 270:4387-4394.
21. Kristie, T. M, J. L. Vogel, and A. E. Sears. 1999. Nuclear localization of the Cl factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc. Natl. Acad. Sci. USA 96:1229-1233.
22. La Boissiere, S, T. Hughes, and P. O'Hare. 1999. HCF-dependent nuclear import of VP16. EMBO J. 18:480-489.
23. Larsen, C. N., B. A. Krantz, and K. D. Wilkinson. 1998. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37:3358-3368.
24. Larsen, C. N., J. S. Price, and K. D. Wilkinson. 1996. Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues. Biochemistry 35:6735-6744.
25. Li, T., N. I. Naqvi, H. Yang, and T. S. Teo. 2000. Identification of a 26S proteasome-associated UCH in fission yeast. Biochem. Biophys. Res. Com-mun. 272:270-275.
26. Lu, R., P. Yang, S. Padmakumar, and V. Misra. 1998. The herpesviras transactivator VP16 mimics a human basic domain leucine zipper protein, luman, in its interaction with HCF. J. Virol. 72:6291-6297.
27. Luciano, R. L., and A. C. Wilson. 2003. HCF-1 functions as a coactivator for the zinc finger protein Krox20. J. Biol. Chem. 278:51116-51124.
28. Mallery, D. L., C. J. Vandenberg, and K. Hiom. 2002. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J. 21:6755-6762.
29. Maun, H. R., C. Eigenbrot, H. Raab, D. Arnott, L. Phu, S. Bullens, and R. A. Lazarus. 2005. Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity. Protein Sci. 14:1171-1180.
30. Meray, R. K., and P. T. Lansbury, Jr. 2007. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. J. Biol. Chem. 282:10567-10575.
31. Misaghi, S., P. J. Galardy, W. J. Meester, H. Ovaa, H. L. Ploegh, and R. Gaudet. 2005. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate. J. Biol. Chem. 280:1512-1520.
32. Narayanan, A., W. T. Ruyechan, and T. M. Kristie. 2007. The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesviras immediate-early promoters for initiation of infection. Proc. Natl. Acad. Sci. USA 104:10835-10840.
33. Nishikawa, H., W. Wu, A. Koike, R. Kojima, H. Gomi, M. Fukuda, and T. Ohta. 2009. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. Cancer Res. 69:111-119.
34. Piluso, D., P. Bilan, and J. P. Capone. 2002. Host cell factor-1 interacts with and antagonizes transactivation by the cell cycle regulatory factor Miz-1. J. Biol. Chem. 277:46799-46808.
35. Qiu, X. B., S. Y. Ouyang, C. J. Li, S. Miao, L. Wang, and A. L. Goldberg. 2006. hRpnl3/ADRMl/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J. 25:5742-5753.
36. Simmen, K. A., A. Newell, M. Robinson, J. S. Mills, G. Canning, R, Handa, K. Parkes, N. Borkakoti, and R. Jupp. 1997. Protein interactions in the herpes simplex virus type 1 VP16-induced complex: VP16 peptide inhibition and mutational analysis of host cell factor requirements. J. Virol. 71:3886-3894.
37. Smith, E. R., C. Cayrou, R. Huang, W. S. Lane, J. Cote, and J. C. Lucchesi. 2005. A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol. Cell. Biol. 25:9175-9188.
38. Song, L., and M. Rape. 2008. Reverse the curse-the role of deubiquitination in cell cycle control. Curr. Opin. Cell Biol. 20:156-163.
39. Stone, M, R. Hartmann-Petersen, M. Seeger, D. Bech-Otschir, M. Wallace, and C. Gordon. 2004. Uch2/Uch37 is the major deubiquitinating enzyme associated with the 26S proteasome in fission yeast. J. Mol. Biol. 344:697-706.
40. Tyagi, S., A. L. Chabes, J. Wysocka, and W. Herr. 2007. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol. Cell 27:107-119.
41. Ventii, K. H., N. S. Devi, K. L. Friedrich, T. A. Chernova, M. Tighiouart, E. G. Van Meir, and K. D. Wilkinson. 2008. BRCAl-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res. 68:6953-6962.
42. Wilson, A. C., M. Boutros, K. M. Johnson, and W. Herr. 2000. HCF-1 amino-and carboxy-terminal subunit association through two separate sets of interaction modules: involvement of fibronectin type 3 repeats. Mol. Cell. Biol. 20:6721-6730.
43. Wilson, A, C, R. N. Freiman, H. Goto, T. Nishimoto, and W. Herr. 1997. VP16 targets an amino-terminal domain of HCF involved in cell cycle progression. Mol. Cell. Biol. 17:6139-6146.
44. Wilson, A. C, M. G. Peterson, and W. Herr. 1995. The HCF repeat is an unusual proteolytic cleavage signal. Genes Dev. 9:2445-2458.
45. Wing, S. S. 2003. Deubiquitinating enzymes: the importance of driving in reverse along the ubiquitin-proteasome pathway. Int. J. Biochem. Cell Biol. 35:590-605.
46. Wysocka, J., and W. Herr. 2003. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem. Sci. 28:294-304.
47. Wysocka, J., M. P. Myers, C. D. Laherty, R. N. Eisenman, and W. Herr. 2003. Human Sin3 deacetylase and trithorax-related Setl/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev. 17:896-911.
48. Wysocka, J., P. T. Reilly, and W. Herr. 2001. Loss of HCF-1 -chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol. Cell. Biol. 21:3820-3829.
49. Yao, T., L. Song, W. Xu, G. N. DeMartino, L. Florens, S. K. Swanson, M. P. Washburn, R. C. Conaway, J. W. Conaway, and R. E. Cohen. 2006. Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrml. Nat. Cell Biol. 8:994-1002.
50. Yokoyama, A., Z. Wang, J. Wysocka, M. Sanyal, D. J. Aufiero, I. Kitabayashi, W. Herr, and M. L. Cleary. 2004. Leukemia proto-oncoprotein MLL forms a SETl-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24:5639-5649.